期刊文献+

阻断氯通道对人喉癌裸鼠移植瘤ERK1/2和AKT1的影响 被引量:2

Effect of blocking chloride channels on the ERK1/2,AKT1 of the human laryngeal carcinoma xenograft tumors in nude mice
暂未订购
导出
摘要 目的研究氯通道阻断剂5-硝基-2-(3-苯丙氨基)苯甲酸[5-nitro-2-(3-phenylpropylamino)benzoicacid,NPPB],对人喉癌细胞系Hep-2细胞裸鼠移植瘤细胞外调节激酶(extracellulat regulated kinase,ERK)ERK1/2和AKT1蛋白磷酸化的影响,探讨阻断氯通道对喉癌移植瘤抑制作用的可能机制。方法以人喉癌Hep-2细胞建立裸鼠皮下移植瘤模型,应用不同浓度的NPPB分组进行治疗实验,研究移植瘤生长变化,Westernblot法检测移植瘤ERK1/2和AKT1蛋白磷酸化水平的变化。结果与对照组比较,各治疗组移植瘤ERK1/2和AKT1总蛋白水平无显著性差异,50、100、150μmol NPPB组ERK1/2和AKT1蛋白磷酸化水平明显降低,差异均有显著性,NPPB浓度依赖性地抑制ERK1/2和AKT1蛋白磷酸化。结论体内阻断氯通道可以抑制人喉癌裸鼠移植瘤的生长,其机制可能与抑制移植瘤细胞ERK1/2和AKT1蛋白磷酸化有关。 OBJECTIVE To study the effect of blocking chloride ion channels on the phosphorylated ERK1/2, AKT1 protein levels of the human laryngeal carcinoma xenograft tumors in nude mice. METHODS Hep-2 cells were seeded subcutaneously into the nude mice to establish human laryngeal carcinoma xenograft models and then treated with PBS and different concentration of NPPB respectively. The changes of the xenograft tumors were studied. Western blot was used to determine the phosphorylated ERK1/2, AKT1 protein levels of the xenograft tumor cells. RESULTS The size and mass of the tumors in the experimental groups (50, 100, 150 μmol NPPB) were significantly decreased (P〈0.05) than that in the control group. The expression of total protein of ERK1/2 and Aktl in the xenograft tumors in the experimental groups (50, 100, 150 μmol NPPB) were not significantly (P〉0.05) changed. Compared with the control group, the phosphorylation levels of ERK1/2 and AKT1 in the experimental groups (50, 100, 150 μmol NPPB/ were significantly (P〈0.05) decreased. CONCLUSION Blocking chloride channels could inhibit the growth of laryngeal carcinoma xenograft tumors in nude mice. The mechanism of the effect might be related to down phosphorylation of ERK1/2 and AKT1 protein.
出处 《中国耳鼻咽喉头颈外科》 CSCD 2013年第1期17-20,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 河南省卫生科技创新人才(2010141) 河南省高校青年骨干教师资助计划(2010GGJS-120)联合资助
关键词 喉肿瘤 鳞状细胞 氯化物通道 模型 动物 移植瘤 Laryngeal Neoplasms CarcinomaSquamous Cell Chloride Channels Models, Animalxenograft tumor
  • 相关文献

参考文献3

二级参考文献52

  • 1Chong H, Vikis HG, Guan KL. Mechanisms of regulating the Raf kinase family. Cell Signal,2003.15(5):463-469.
  • 2Hilger RA, Scheulen ME, Strumberg D. The Ras-Raf-MEK-ERK pathway in the treatment of cancer.Onkologie,2002,25(6):511-518.
  • 3Andresen BT, Rizzo MA, Shome K, et al. The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBSLett,2002, 531(1): 65-68.
  • 4Anders M, Christian C, McMahon M, et al. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receotor in cancer cells. Cancer Res,2003,63(9):2088-2095.
  • 5Anders M, Christian C, McMahon M, et al. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.Cancer Res,2003,63(9):2088-2095.
  • 6McDaid HM, Horwitz SB. Selective potentiation of paclitaxel (taxol)induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. Mol Pharmacol, 2001,60(2):290-301.
  • 7Choi KC, Auersperg N, Leung PC. Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium. Reprod Biol Endocrinol,2003, 1 (1): 71-72.
  • 8Liu B, Fang M, Lu Y, et al. Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in si-Ha human cervical cancer cells.Br J Cancer,2001,85(2):303-311.
  • 9Seidman R, Gitelman I, Sagi O, et al. The Role of ERK 1/2 and p38 MAP-Kinase Pathways in Taxol-Induced Apoptosis in human ovarian carcinoma cells. Exoerimental Cell Res,2001, 268(1): 84-92.
  • 10Denkert C, Koch I, Berger S,et al. Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells. Cancer Lett, 2003,195(1): 101 - 109.

共引文献27

同被引文献23

  • 1Li J, Huang X, Xie X, et al. Human telomerase reverse transcriptase regulates cyclin D1 and G1/S phase transition in laryngeal squamous carcinoma. Acta Otolaryngol, 2011,131: 546-551.
  • 2Ma D, Tao X, Gao miRNA in hepatoce F, et al. MiR-224 functions as an onco- lular carcinoma cells by activating AKT signaling. Oncol Lett, 2012, 4: 483-488.
  • 3Scisciani C, Vossio S, Guerrieri F, et al. Transcriptional regulation of miR-224 upregulated in human HCCs by NFKB inflammatory pathways. J Hepatol, 2012, 56: 855-861.
  • 4Lu S, Wang S, Geng S, et al. Upregulation of microRNA-224 confers a poor prognosis in glioma patients. Clin Transl Oncol, 2013, 15: 569-574.
  • 5Mavridis K, Stravodimos K, ScorilasA. Downregulation and prognostic performance of microRNA 224 expression in prostate cancer. Clin Chem, 2013, 59: 261-269.
  • 6Shen SN, Wang LF, Jia YF, et al. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn Pathol, 2013, 30: 565-575.
  • 7Huang L, Dai T, Lin X, et al. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun, 2012, 425: 127-133.
  • 8Liao WT, Li TT, Wang ZG, et al. MicroRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2. Clin Cancer Res, 2013. 17: 4662-4772.
  • 9Wang Y, Ren J, Gao Y, et al. MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival. PLoS One, 2013, 8: 68744.
  • 10Matsuo H, Yokooji T, Morita H, et al. Aspirin augments IgE - medi- ated histamine release from human peripheral basophils via syk kinase activation[J]. Allergol Iut, 2013, 62(4): 503-511.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部